Finance Ministry relaxes norms for sourcing Covid-19 relief materials
May 10, 2021
The Finance Ministry notified amendments to General Financial Rules in May 2020 - Getty Images×
Global tenders for procurement of less than ₹200 cr allowed till May 31
The Finance Ministry has relaxed procurement norms for sourcing Covid-19 relief materials. These include permitting global tender to be floated for a value of less than ₹200 crore and procurement of the same item at different rates.
These instructions will be applicable to the Department of Pharma, the Ministry of Health & Family Welfare and the Defence Research & Development Organisation (DRDO). “The instruction in this Department’s OM (Office Memorandum) dated May 15, 2020 specifying that no Global Tender Enquiries(GT) shall be invited for tenders up to ₹200 crore shall stand relaxed, and hence, it shall be permissible to invite GTE where necessary,” the new OM dated April 24 said, on the website of the Finance
URL copied
Covid India LIVE Updates
With the second wave of Covid-19 spreading wider across the country, it has become of utmost importance to follow all the safety precautions. This wave is even deadlier than before. One of the most important of these guidelines is to get vaccinated. Across the globe medical professionals advise one should get the vaccine as soon as possible. Healthcare and infrastructure is reeling under pressure, and thus, it is incumbent on each and every one of us to be responsible and try to follow safety protocols and guidelines.
It is important to keep yourself updated about the latest guidelines on Covid19 safety. Here are all the health updates on Covid19 that you need to know-
COVID-19 vaccine: Govt issues company-wise supply plan of Remdesivir to states, UTs
The companies have been instructed to ensure timely supplies of Remdesivir to all states/UTs strictly as per the supply plan
BusinessToday.In | May 8, 2021 | Updated 15:08 IST
The development comes in continuation to the allocation of Remdesivir to states/UTs done on Friday, May 7
The Centre on Saturday, May 8, issued a company-wise supply plan of antiviral drug Remdesivir to states and Union Territories (UTs). Remdesivir is a key drug used in the treatment of COVID-19 patients. The company-wise supply plan of Remdesivir for the period April 21 to May 16 has been issued to states/UTs, read an official statement by the Ministry of Chemicals and Fertilizers.
Share Via:
In the absence of any official messaging, the public has come to depend on âWhatsapp Universityâ and other unreliable sources of information.
Have you been overwhelmed and confused by scores of âexpertsâ holding forth on the Covid wave raging through India? Talking heads on TV, online and print opinion pieces, research findings, âWhatsApp Universityâ.
Let us condense the currently available wisdom on strategies to manage the Covid crisis:
Logistics management to connect oxygen availability to demand
Fast-tracking vaccine supplies
Ramping up testing
Decentralised, 24x7 war rooms that counsel patients and use real time data to connect them with ambulances, beds etc.
To ensure smooth supply of remdesivir used in the treatment of COVID-19 across the country, the allocation of the antiviral drug to the states and union territories has been made up to May 16, Union Chemicals and Fertilisers Minister Sadananda Gowda said on Friday. The production capacity of remdesivir has been increased to 1.03 crore vials per month, up from 38 lakh vials per month earlier, the minister had said on Tuesday. Considering the requirement of Remdesivir in every state and ensuring its adequate availability, allocation of #Remdesivir has been made upto 16th May 2021. This will ensure smooth supply of Remdesivir across country so that no patient face difficulty in this #pandemic time, Gowda said in a tweet.